Elizabeth Reed, VP, General Counsel at Eiger Biopharmaceuticals, holds 169.00 shares in Eiger Biopharmaceuticals (Ticker: EIGRQ), holds 76.27K shares in Travere Therapeutics (Ticker: TVTX). Most recently, Elizabeth Reed ― shares of Eiger Biopharmaceuticals on ― for an estimated value of ―.